Case study: Cannabis might dampen the pain, but amplify the psychosis!

FHS
May 7, 2024
4:27 am

Case study details a 27-year-old woman with schizoaffective disorder and fibromyalgia who used high-potency cannabis to alleviate pain but experienced adverse psychiatric effects. A month-long diet lowering free glutamate improved her pain, mental health, and allowed her to quit cannabis, highlighting the risks of cannabis self-medication for pain management.

Novartis spotlights psoriatic arthritis and Cosentyx with award-winning chef and restaurant owner

Celebrity chef and restaurateur Michelle Bernstein is cooking up savory dishes alongside psoriatic arthritis discussions as the spokesperson for Novartis’ “PsAvor Life” campaign. She knows

September 26, 2023

NAFLD and T2DM Bodes Higher Risk of Liver Decompensation, Cancer

Patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes may be at significantly higher risk of hepatic decompensation and liver cancer, researchers reported.

July 12, 2023

Study links gut microbiome modulation to changes in social behavior

Taking pro- and prebiotics could make people more sensitive to fairness, even at the cost of earning less money, according to a study.

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.